Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first coronary or cerebrovascular ischaemic event and following coronary angioplasty or coronary artery bypass graft.

A dose of one capsule (162.5mg acetylsalicyclic acid) should be taken at the same time each day 15 minutes before food.

Flamasacard is not suitable in situations where a rapid onset of action is required, such as the acute treatment of myocardial infarction or unstable angina. In these cases immediate-release aspirin should be administered.

View Flamasacard drug record

Further information: Abbey Pharmaceuticals

 

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Avoid benzodiazepines in opioid-dependent patients, GPs reminded

Avoid benzodiazepines in opioid-dependent patients, GPs reminded

Prescribing benzodiazepines in opioid-dependent individuals...

Flu antivirals approved for NHS prescribing as cases increase

Flu antivirals approved for NHS prescribing as cases increase

GPs can now prescribe antiviral medicines for flu prophylaxis...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

New e-cigarette alternative launched on prescription

New e-cigarette alternative launched on prescription

Voke, a new nicotine inhaler, is available to prescribe...